LEUKEMIA AND LYMPHOMA
Europe and the USA
Linking Knowledge and Practice

3 - 5 October 2018

Valamar Lacroma Dubrovnik Hotel
Dubrovnik, Croatia

Don't Miss Out Register Now!

Exhibitor, Sponsor & ISS by 1 August 2018
Abstract Submission by 15 August 2018

This meeting is a joint effort of The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; The School of Medicine, University of Zagreb, Zagreb, Croatia, organized by Jonathan Wood & Associates, an MDedge Company. The theme of the meeting, Europe and the US Linking Knowledge and Practice, reflects the collaboration to advance the research and treatment of patients with hematologic malignancies globally.

In an effort to broaden international collaborations, this Congress is endorsed by:
The Croatian Society of Hematology
The Croatian leukemia and Lymphoma Society (HULL)

Organized by:


EVENT WILL START IN
  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

CO-CHAIRS

avatar Hagop Kantarjian, MD

Professor and Chair Department of Leukemia MD Anderson Cancer Center Houston, TX, USA

avatar Srdan Verstovsek, MD, PhD

Professor of Medicine Department of Leukemia MD Anderson Cancer Center Houston, TX, USA

avatar Boris Labar, MD, PhD

Associate Professor Department of Medicine Clinical Hospital Center Zagreb Zagreb, Croatia

FACULTY

Lionel Ades, MD, PhD

Hôpital Saint Louis
Paris, France

Michele Baccarani, MD

University of Bologna
Institute of Hematology "L. e A. Seràgnoli"
Bologna, Italy

Ali Bazarbachi, MD, PhD

American University of Beirut Medical Center
Beirut, Lebanon

Niccolò Bolli, MD, PhD

Università degli Studi di Milano
Fondazione IRCCS Istituto
Nazionale dei Tumori Milan, Italy

Jorge Cortes, MD

The University of Texas
MD Anderson Cancer Center Houston, TX, USA

Claire E. Dearden, MD

The Royal Marsden
NHS Foundation Trust Sutton, Surrey, UK

Stéphane de Botton, MD, PhD

University Paris-Saclay, Gustave Roussy
Villejuif, France

Matteo G Della Porta, MD

Cancer Center - IRCCS
Humanitas Research Hospital
Humanitas University
Milan, Italy

Peter Dreger, MD

Heidelberg University Hospital
Heidelberg, Germany

Madeleine Duvic, MD

University of Texas
MD Anderson Cancer Center
Houston, TX, USA

Nadira Durakovic, MD, PhD

University of Zagreb School of Medicine,
University Hospital Center Zagreb Zagreb, Croatia

Fabio Efficace, PhD

Health Outcomes Research Unit
Italian Group for Adult Hematologic Disease (GIMEMA)
GIMEMA Data Center, Rome, Italy

Nathan H. Fowler, MD

University of Texas
MD Anderson Cancer Center
Houston, TX, USA

Carlo Gambacorti-Passerini, MD

University of Milano Bicocca S.Gerardo Hospital
Monza, Italy

Maria Gavriatopoulou, MD

Alexandra Hospital, National and Kapodistrian
University of Athens
Athens, Greece

Claudia Haferlach, MD

MLL Munich Leukemia Laboratory GmbH
Munich, Germany

Anton Hagenbeek, MD, PhD

Academic Medical Center University of Amsterdam, The Netherlands
Amsterdam, The Netherlands

Claire Harrison, MD

Guy’s and St Thomas’ Hospital NHS Trust
St Thomas’ Hospital London, UK

Dirk Hose, MD

University Hospital Heidelberg
Heidelberg, Germany

Hagop Kantarjian, MD

cochairman

Professor and Chair
Department of Leukemia
MD Anderson Cancer Center Houston, TX, USA

Partow Kebriaei, MD

University of Texas
MD Anderson Cancer Center Houston, TX, USA

Rajko Kusec, MD, PhD

Dubrava University Hospital
University of Zagreb School of Medicine
Zagreb, Croatia

Boris Labar, MD, PhD

cochairman

Associate Professor
Department of Medicine Clinical Hospital Center Zagreb Zagreb, Croatia

Heather Landau, MD

Memorial Sloan-Kettering Cancer Center
New York, NY, USA

Luca Malcovati, MD

University of Pavia
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy

Jean-Pierre Marie, MD

Department of Hematology
Saint-Antoine Hospital, AP-HP Paris, France

Emili Montserrat, MD, PhD

Emeritus Professor of Medicine
CLL and Lymphoma Program
Hospital Clinic, University of Barcelona
Barcelona, Spain

Owen A. O’Connor, MD, PhD

Columbia University Medical Center
The New York Presbyterian Hospital
New York, NY, USA

Yishai Ofran, MD

Rambam Health Care Campus
Haifa, Israel

Francesco Passamonti, MD

University of Insubria
Varese Circolo Hospital ASST Seven Lakes
Varese, Italy

Uwe Platzbecker, MD

University Hospital Carl Gustav Carus Dresden
Dresden, Germany

Farhad Ravandi, MD

University of Texas
MD Anderson Cancer Center
Houston, TX, USA

Andreas Reiter, MD

University Hospital Mannheim
Mannheim, Germany

Davide Rossi, MD, PhD

Oncological Institute of Italian Switzerland (IOSI)
Bellinzona, Switzerland

Valeria Santini, MD

AOU Careggi
University of Florence
Florence, Italy

Matjaz Sever, MD

University Hospital Dubrava
Zagreb, Croatia

Richard Stone, MD

Harvard Medical School
Boston, MA, USA

Max S. Topp, MD

University Hospital Würzburg
Würzburg, Germany

Marek Trneny, MD, CSc.

Charles University General Hospital
Praha, Czech Republic

Srdan Verstovsek, MD, PhD

cochairman

Professor of Medicine Department of Leukemia MD Anderson
Cancer Center Houston, TX, USA

Nikolas von Bubnoff, MD

University Hospital Freiburg
Freiburg, German

Toni Valković, MD, PhD

University Clinical Centre
Rijeka, Croatia

William Wierda, MD

University of Texas
MD Anderson Cancer Center Houston, TX, USA

Samo Zver, MD, PhD

University Clinical Center Ljubljana
Ljubljana, Slovenia

THE SCHEDULE

Registration

7:15 - 15:00

Keynote Address

14:00 - 15:00

Acute Lymphocytic Leukemias

15:00 - 17:00

Acute Myeloid Leukemias

17:00 - 19:00

Welcome Dinner

19:00 - 21:00

*Faculty and sessions are subject to change

Morning Symposium

7:15 - 9:00

Myeloproliferative Neoplasms

9:00 - 11:30

Myelodysplactic Syndromes

11:30 - 13:30

Lunch Symposium

13:30 - 15:00

Chronic Myeloid Leukemias

15:00 - 16:30

Chronic Lymphocytic Leukemias

16:30 - 18:00

Oral Poster Presentations

18:00 - 19:00

Poster Walk Reception

19:00 - 20:00

*Faculty and sessions are subject to change

Morning Symposium

7:15 - 9:00

B-Cell Lymphomas

9:00 - 11:45

T-Cell Lymphomas

11:45 - 13:00

Lunch Symposium

13:00 - 14:45

Multiple Myeloma

14:45 - 16:30

REGISTRATION

1st SEPTEMBER 2018 and on site
  • MD/DO €500
  • Industry €1200
REGISTER NOW

HOTEL

Valamar Lacroma Dubrovnik Hotel

Dubrovnik, Croatia


Make Reservation

Valamar Lacroma Dubrovnik Hotel, the proud recipient of the prestigious 2013, 2015, 2016 and 2017 World Travel Award as "Croatia's Leading Hotel" and the 2014, 2015, 2016 and 2017 World Travel Award as "Croatia's Leading Business Hotel", is located on the tranquil Babin Kuk peninsula, surrounded by pine tree forests and soothing white pebble beaches.

Caesars Palace Hotel

Please register and book your hotel room early

Make Reservation

Caesars Palace Hotel

Early Registration through 1 July 2018

Make Reservation

Caesars Palace Hotel

Please click here for hotel reservations

Make Reservation

SATELLITE SYMPOSIA

BENEFITS OF INDEPENDENT SATELLITE SYMPOSIA
Independent Satellite Symposia (ISS) are one of the most popular contributor options at Leukemia & Lymphoma 2018 for a number of reasons. A satellite symposium provides:

  • A high level of visibility and the opportunity to highlight your organization’s position as a leader in the hematology/oncology field.
  • A highly respected forum for representing important innovations and cutting-edge research.
  • A ‘ready-made’ audience of the leading physicians and researchers actively practicing in the research and treatment of patients diagnosed with hematologic malignancies such as leukemia, lymphoma, multiple myeloma, MDS, MPNs and transplant.
  • Increased recognition and goodwill among thought leaders in the hematology/oncology field.
  • An exclusive time slot, an overview of the symposium in the Meeting Program, the option to insert an invitation in to the official conference bag, and prominent contributor signage outside of the symposium area.

Download the Prospectus for additional information, guidelines, and forms.

EXHIBITOR INFORMATION

Exhibitor Benefits

  • Complimentary listing of company name and booth number in the Leukemia & Lymphoma 2018 Program and Abstracts Book/Final Program (provided to all registered delegates/attendees)
  • Listing on the Leukemia & Lymphoma 2018 website
  • Complimentary registrations for each exhibitor including exhibit-hall-only badges, full meeting badge(s) and guest passes, depending upon level of contribution
  • Access to education programs, depending on level of contribution
  • Other benefits related to each support opportunity as described in other sections of this prospectus

Download the Prospectus for additional information, guidelines, and forms.

location icon
ADDRESS

Jonathan Wood & Associates,
an MDedge Company

7 Century Drive
Parsippany, NJ 07054
973-290-8223
info@jwoodassoc.com

email icon
CONFERENCE QUESTIONS?

Damaris Cruz
973-290-8223
dcruz@jwoodassoc.com

SPONSORSHIP QUESTIONS?

bd@mdedge.com